6-Amino-1,2-benzisoxazole, 95.0%, 100mg

12-Hydroxystearic Acid>80.0%(GC)25g

trans-1,4-Cyclohexanedicarboxylic Acid>97.0%(GC)(T)25g

[(5-Bromopentyl)oxy](tert-butyl)dimethylsilane, 95%, 1g

(S)-5-Bromo-2,3-dihydrobenzofuran-3-amine hydrochloride, 98%, 1g

3-(4-Hydroxypiperidin-1-yl)propanenitrile, 95%, 5g

2-Amino-5-iodobenzamide, 98%, 250mg

Acide 4-nitrobenzoïque, min 99,5 %, 500 g, emballage plastique.

N'-{5-[(2E)-3-(dimethylamino)-2-propenoyl]-4-methyl-1,3-thiazol-2-yl}-N,N-dimethylimidoformamide, 95.0%, 5g

1,6-Dibromoisoquinolin-3-amine, 95.0%, 100mg

4-bromo-2-{[(butan-2-yl)amino]methyl}phenol hydrochloride, 95.0%, 10g

2.68M HCl in 1,4-Dioxane (HCl 10% w/w), 100ml

6-Methyl-1,2,3,4-tetrahydroquinoxaline, 98%, 100mg